Abstract
One hundred strains of Haemophilus ducreyi isolated in Thailand from patients with chancroid were tested by the agar dilution method against 10 antimicrobial agents and typed by outer membrane protein pattern by using sodium dodecyl sulfate gel electrophoresis. All strains produced beta-lactamase and were resistant to tetracycline, kanamycin, and sulfonamides. Most had a decreased susceptibility to trimethoprim (MIC for 50% of the strains [MIC50], 0.5 micrograms/ml) and chloramphenicol (MIC50, 8 micrograms/ml). Strains were susceptible to ciprofloxacin (MIC90, 0.001 micrograms/ml), ceftriaxone (MIC50, 0.0015 micrograms/ml), erythromycin (MIC50, 0.015 micrograms/ml), rosoxacin (MIC50, 0.03 micrograms/ml), and spectinomycin (MIC50, 8 micrograms/ml). The degree of antimicrobial resistance found in Thailand is higher than that reported for H. ducreyi isolated in other regions. Five different outer membrane protein patterns were found by analyzing proteins in the range of 29 to 61 kilodaltons, but 98% of the Thai strains fell into three patterns which did not differ greatly. Outer membrane protein patterns of Thai strains were also seen in strains from other geographic areas. A new outer membrane protein type was found among nine strains isolated in Singapore.
Full text
PDF


Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bilgeri Y. R., Ballard R. C., Duncan M. O., Mauff A. C., Koornhof H. J. Antimicrobial susceptibility of 103 strains of Haemophilus ducreyi isolated in Johannesburg. Antimicrob Agents Chemother. 1982 Oct;22(4):686–688. doi: 10.1128/aac.22.4.686. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Carpenter J. L., Back A., Gehle D., Oberhoffer T. Treatment of chancroid with erythromycin. Sex Transm Dis. 1981 Jul-Sep;8(3):192–197. doi: 10.1097/00007435-198107000-00004. [DOI] [PubMed] [Google Scholar]
- Duncan M. O., Bilgeri Y. R., Fehler H. G., Ballard R. C. Treatment of chancroid with erythromycin. A clinical and microbiological appraisal. Br J Vener Dis. 1983 Aug;59(4):265–268. doi: 10.1136/sti.59.4.265. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fast M. V., Nsanze H., D'Costa L. J., Karasira P., Maclean I. W., Piot P., Albritton W. L., Ronald A. R. Antimicrobial therapy of chancroid: an evaluation of five treatment regimens correlated with in vitro sensitivity. Sex Transm Dis. 1983 Jan-Mar;10(1):1–6. [PubMed] [Google Scholar]
- Fast M. V., Nsanze H., Plummer F. A., D'Costa L. J., MacLean I. W., Ronald A. R. Treatment of chancroid. A comparison of sulphamethoxazole and trimethoprim-sulphamethoxazole. Br J Vener Dis. 1983 Oct;59(5):320–324. doi: 10.1136/sti.59.5.320. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hammond G. W., Lian C. J., Wilt J. C., Ronald A. R. Antimicrobial susceptibility of Haemophilus ducreyi. Antimicrob Agents Chemother. 1978 Apr;13(4):608–612. doi: 10.1128/aac.13.4.608. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hammond G. W., Lian C. J., Wilt J. C., Ronald A. R. Comparison of specimen collection and laboratory techniques for isolation of Haemophilus ducreyi. J Clin Microbiol. 1978 Jan;7(1):39–43. doi: 10.1128/jcm.7.1.39-43.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hammond G. W., Slutchuk M., Scatliff J., Sherman E., Wilt J. C., Ronald A. R. Epidemiologic, clinical, laboratory, and therapeutic features of an urban outbreak of chancroid in North America. Rev Infect Dis. 1980 Nov-Dec;2(6):867–879. doi: 10.1093/clinids/2.6.867. [DOI] [PubMed] [Google Scholar]
- Handsfield H. H., Totten P. A., Fennel C. L., Falkow S., Holmes K. K. Molecular epidemiology of Haemophilus ducreyi infections. Ann Intern Med. 1981 Sep;95(3):315–318. doi: 10.7326/0003-4819-95-3-315. [DOI] [PubMed] [Google Scholar]
- Latif A. S., Lencioni R., Crocchiolo P., Esposito R. Single-dose thiamphenicol for chancroid. Lancet. 1982 Nov 27;2(8309):1225–1225. doi: 10.1016/s0140-6736(82)91252-1. [DOI] [PubMed] [Google Scholar]
- Nsanze H., Fast M. V., D'Costa L. J., Tukei P., Curran J., Ronald A. Genital ulcers in Kenya. Clinical and laboratory study. Br J Vener Dis. 1981 Dec;57(6):378–381. doi: 10.1136/sti.57.6.378. [DOI] [PMC free article] [PubMed] [Google Scholar]
- O'Callaghan C. H., Morris A., Kirby S. M., Shingler A. H. Novel method for detection of beta-lactamases by using a chromogenic cephalosporin substrate. Antimicrob Agents Chemother. 1972 Apr;1(4):283–288. doi: 10.1128/aac.1.4.283. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Odumeru J. A., Ronald A. R., Albritton W. L. Characterization of cell proteins of Haemophilus ducreyi by polyacrylamide gel electrophoresis. J Infect Dis. 1983 Oct;148(4):710–714. doi: 10.1093/infdis/148.4.710. [DOI] [PubMed] [Google Scholar]
- Plummer F. A., D'Costa L. J., Nsanze H., Dylewski J., Karasira P., Ronald A. R. Epidemiology of chancroid and Haemophilus ducreyi in Nairobi, Kenya. Lancet. 1983 Dec 3;2(8362):1293–1295. doi: 10.1016/s0140-6736(83)91161-3. [DOI] [PubMed] [Google Scholar]
- Plummer F. A., D'Costa L. J., Nsanze H., Maclean I. W., Karasira P., Piot P., Fast M. V., Ronald A. R. Antimicrobial therapy of chancroid: effectiveness of erythromycin. J Infect Dis. 1983 Oct;148(4):726–731. doi: 10.1093/infdis/148.4.726. [DOI] [PubMed] [Google Scholar]
- Plummer F. A., Nsanze H., D'Costa L. J., Karasira P., Maclean I. W., Ellison R. H., Ronald A. R. Single-dose therapy of chancroid with trimethoprim-sulfametrole. N Engl J Med. 1983 Jul 14;309(2):67–71. doi: 10.1056/NEJM198307143090202. [DOI] [PubMed] [Google Scholar]
- Rajan V. S., Sng E. H., Lim A. L. The isolation of H. ducreyi in Singapore. Ann Acad Med Singapore. 1983 Jan;12(1):57–60. [PubMed] [Google Scholar]
- Slootmans L., Vanden Berghe D. A., Van Dyck E., Piot P. Susceptibility of 40 Haemophilus ducreyi strains to 34 antimicrobial products. Antimicrob Agents Chemother. 1983 Oct;24(4):564–567. doi: 10.1128/aac.24.4.564. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sng E. H., Lim A. L., Rajan V. S., Goh A. J. Characteristics of Haemophilus ducreyi. A study. Br J Vener Dis. 1982 Aug;58(4):239–242. doi: 10.1136/sti.58.4.239. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sottnek F. O., Biddle J. W., Kraus S. J., Weaver R. E., Stewart J. A. Isolation and identification of Haemophilus ducreyi in a clinical study. J Clin Microbiol. 1980 Aug;12(2):170–174. doi: 10.1128/jcm.12.2.170-174.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sturm A. W., Zanen H. C. Drug of choice for chancroid. Lancet. 1983 Jan 15;1(8316):125–125. doi: 10.1016/s0140-6736(83)91766-x. [DOI] [PubMed] [Google Scholar]
- Taylor D. N., Duangmani C., Suvongse C., O'Connor R., Pitarangsi C., Panikabutra K., Echeverria P. The role of Haemophilus ducreyi in penile ulcers in Bangkok, Thailand. Sex Transm Dis. 1984 Jul-Sep;11(3):148–151. doi: 10.1097/00007435-198407000-00005. [DOI] [PubMed] [Google Scholar]